MILWAUKEE, July 18, 2023 /PRNewswire/ -- Ademi LLP is investigating Neoleukin (Nasdaq:NLTX) for possible breaches of fiduciary duty and other violations of law in its private placement and its transaction with Neurogene.
Read more at prnewswire.comShareholder Alert: Ademi LLP investigates whether Neoleukin Therapeutics, Inc. has obtained a Fair Price in its Private Placement and its transaction with Neurogene
PR Newswire -
Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here